The study population consisted of women undergoing cesarean section in Shohada-e-Tajrish Hospital of Tehran, Iran, and their newborns. The subjects were selected randomly. The sample size was calculated based on the mean and CSI standard deviation of the mothers in both groups. The mean and standard deviation of neonatal Apgar score were not used because first of all there is no similar study measuring the Apgar score difference after intrathecal dexmedetomidine injection, and secondly, neonatal Apgar score is variable based on maternal conditions and is affected by various maternal factors. We used the previous study data to determine the sample size and we obtained the following numbers:

µ1 = CSI mean in dexmedmotidine group = 74,
µ2 = CSI mean in control group = 82,
S1= CSI standard deviation in dexmedmotidine group,
S2 = CSI standard deviation in control group,
Accordingly, the sample size was calculated at about 76 in each group:
This randomized double-blind study was performed after approving the title, registering the proposal, and obtaining a code of ethics from in Shohada-e-Tajrish Hospital in Tehran (code of ethics: IR.SBMU.FNM.REC.1396.2684).
Prior to the initiation of the study, a written informed consent was obtained from the patients who met the inclusion criteria.
The inclusion criteria consisted of maternal age between 20 and 25 years, no history of preeclampsia, no premature embryo, no twin gestations, no history of hypersensitivity or anaphylactic shock, and no spinal anesthesia contraindications.
The exclusion criteria comprised long duration of cesarean section leading to general anesthesia, massive hemorrhage, placenta accreta, increta and precreta during operation, or any other event that interrupts routine cesarean section and leads to non-routine interventions.
Patients were divided into two groups based on random number table. The case group received 10 mg of dexmedetomidine diluted in 4 cc of bupivacaine 0.5%, and the control group received 4 cc of bupivacaine 0.5% plus 1 cc of normal saline.
The volume of the anesthetic drug was reached to 3 ml by normal saline 0.9% in order to equalize the amounts of drugs used in the two groups. Each group received 3.5 cc of either BV or BVD solutions.
None of the patients received any premedication. Before starting anesthesia, IV line was accessed, and fluid therapy by normal saline 5 cc/kg was routinely performed. During the operation, standard fluid therapy was administered.
Monitoring during operation included the control of vital signs such as blood pressure, heart rate, and peripheral pulse oximetry to evaluate the hemodynamic status of the patients. Also, all the patients received 5 L of oxygen per minute by face mask during the operation.
3.1. Nerve Block
Spinal block was obtained in sitting position by a 25-gauge needle, and intrathecal injection was performed at a rate of 0.2 mL/s. After the procedure, the patients stayed in supine position. In cases that the sensory block did not reach to the sensory level of T6 after 20 seconds, spinal block was changed to general anesthesia.
3.2. Spinal Block Monitoring
The patients’ respiratory and hemodynamic parameters included mean blood pressure, heart rate per minute, respiratory rate per minute, and oxygen saturation before the block, immediately after the block, every two minutes during the operation till delivery, every 30 minutes till the end of the operation, and 180 minutes after the end of the operation. In cases where systolic blood pressure dropped to 20% of baseline and blood pressure or systolic blood pressure dropped to lower than 100 mmHg, sufficient fluid and incremental phenylephrine were injected. In cases where the heart rate of the patient reduced to below 55 or the patient had nausea and normal blood pressure, 0.5 mg atropine was injected.
In this study, we used the Ramsay Sedation Scale to assess the level of patients’ sedation during cesarean section. The amount of pain during operation and the need for postoperative analgesics were also measured by visual analogue scale (VAS). In cases where VAS was more than 4, diclofenac suppository was used to assuage pain. Also, in order to measure the depth of anesthesia, the BIS (as an electroencephalography-related monitoring) was used. Apgar score was also applied to evaluate the effect of bupivacaine and dexmedetomidine on neonates at birth and 5 minutes after birth by a pediatrician who was not involved in the study and was unaware of the group allocations.